CIK: 0001295438
Total reported value
$62.4M
Reporting period: 2016-09-30 · Number of holdings: 4
Polaris Venture Management Co IV LLC disclosed 4 holdings in its latest 13F filing for the period ending 2016-09-30, with total reported value of $62.4M and a quarterly turnover rate of 10.0%.
Browse other institutions with under $100M AUMBrowse other institutions starting with "P"
Sector classification currently covers about 0% of this portfolio's disclosed value; the remainder includes holdings (e.g. unmapped tickers, options, or other security types) not yet covered by our sector mapping.
Trim 15708Q105
0.0% -$1.5M
Add XLRN
0.0% $3.3M
Add ALIMEUR
0.0% $818.0K
Trim 74584P103
0.0% -$493.0K
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | XLRN | Acceleron Pharma INC | Stock-Other | 85.86% | +2.50% | — | |
| 2 | ALIMEUR | Alimera Sciences INC | Stock-Other | 7.52% | +1.10% | — | |
| 3 | ✓ | Pulmatrix INC | Stock-Other | 4.21% | -0.96% | — | |
| 4 | ✓ | Cerulean Pharma INC | Stock-Other | 2.41% | -2.64% | — |
Not enough priced holdings yet to compute performance
Not enough sector-mapped data yet
| Period | Holdings | Total value | Stability | Top holdings |
|---|---|---|---|---|
| 2016-09-30 | 4 | $62.4M | 10 | |
| 2016-06-30 | 4 | $60.3M | 27 | |
| 2016-03-31 | 4 | $53.1M | 52 | |
| 2015-12-31 | 4 | $90.5M | 52 | |
| 2015-09-30 | 4 | $56.9M | 51 | |
| 2015-06-30 | 4 | $96.1M | 50 | |
| 2015-03-31 | 3 | $119.9M | 12 | |
| 2014-12-31 | 3 | $126.9M | 16 | |
| 2014-09-30 | 3 | $107.9M | 13 | |
| 2014-06-30 | 3 | $122.4M | 33 | |
| 2014-03-31 | 3 | $151.5M | 13 | |
| 2013-12-31 | 3 | $150.5M | 0 |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | XLRN | Acceleron Pharma INC | +2.5% | — | Unchanged |
| 2 | ALIMEUR | Alimera Sciences INC | +1.1% | — | Unchanged |
| 3 | ✓ | Pulmatrix INC | -1% | — | Unchanged |
| 4 | ✓ | Cerulean Pharma INC | -2.6% | — | Unchanged |
| Period | Filed | Type | EDGAR |
|---|---|---|---|
| 2016-09-30 | 2017-02-14 | 13F-HR | View on EDGAR |
| 2016-06-30 | 2017-02-14 | 13F-HR | View on EDGAR |
| 2016-03-31 | 2016-05-13 | 13F-HR | View on EDGAR |
| 2015-12-31 | 2016-02-16 | 13F-HR | View on EDGAR |
| 2015-09-30 | 2015-11-10 | 13F-HR | View on EDGAR |
| 2015-06-30 | 2015-08-11 | 13F-HR | View on EDGAR |
| 2015-03-31 | 2015-05-14 | 13F-HR | View on EDGAR |
| 2014-12-31 | 2015-02-17 | 13F-HR | View on EDGAR |
| 2014-09-30 | 2014-10-23 | 13F-HR | View on EDGAR |
| 2014-06-30 | 2014-08-11 | 13F-HR | View on EDGAR |
| 2014-03-31 | 2014-05-01 | 13F-HR | View on EDGAR |
| 2013-12-31 | 2014-02-14 | 13F-HR | View on EDGAR |
Institutions with a similar AUM
CIK 0001807559
Total reported value
$62.4M
14 stks
2026-03-31
AUM within 0.0% of this institution
CIK 0001535279
Total reported value
$62.4M
12 stks
2022-03-31
Stale — no recent filing
AUM within 0.0% of this institution
CIK 0001909569
Total reported value
$62.4M
243 stks
2022-09-30
Stale — no recent filing
AUM within 0.0% of this institution
Institutions with overlapping top holdings
CIK 0001419730
Total reported value
$13.6M
2 stks
2015-09-30
Stale — no recent filing
1 of the top 5 holdings overlap, including Acceleron Pharma INC
CIK 0001424874
Total reported value
$359.2M
3 stks
2020-12-31
Stale — no recent filing
1 of the top 5 holdings overlap, including Alimera Sciences INC